
Minimizing Harm
A New Crime Policy For Modern America
Edward Rubin(Author)
Westview Press Inc
1st Edition
Published on 14. May 1999
Book
Paperback/Softback
222 pages
978-0-8133-6804-7 (ISBN)
Description
This book represents an effort by a number of leading criminologists to articulate a pragmatic crime policy for America-a policy that combines academic insights about crime prevention with the realities of contemporary politics.
More details
Language
English
Place of publication
Oxford
United States
Publishing group
Taylor & Francis Inc
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 229 mm
Width: 152 mm
Thickness: 13 mm
Weight
371 gr
ISBN-13
978-0-8133-6804-7 (9780813368047)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

Book
08/2019
1st Edition
Routledge
€206.30
Shipment within 15-20 days

E-Book
04/2018
1st Edition
Routledge
€63.49
Available for download

E-Book
04/2018
1st Edition
Routledge
€63.49
Available for download
Book
12/1998
1st Edition
Westview Press Inc
€126.28
Article exhausted; check different version
Person
Edward L. Rubin is professor of law at the University of California at Berkeley.
Content
Preface and Acknowledgments -- Introduction: Minimizing Harm as a Solution to the Crime Policy Conundrum -- Public Attitudes Toward Crime -- Comment: When and for Whom Is Violence a Crime Problem? -- Comment: Crime, Violence, and Public Mythology -- Prevention -- Comment: Early Intervention: Promising Path to Cost-Effective Crime Control, or Primrose Path to Wasteful Social Spending? -- Comment: Can We Afford to Prevent Violence? Can We Afford Not To? -- Alternative Sanctions -- Comment: Net Repairing: Rethinking Incarceration and Intermediate Sanctions -- Comment: Intermediate Punishments -- Drug Policy -- Comment: The Ambiguities of Harm Reduction in Crime and Drug Policy -- Comment: Breaking the Impasse in American Drug Policy